european

GAC Shines at IAA MOBILITY Munich with AION V Officially Entering Europe, Accelerating the “European Market Plan”

MUNICH, Sept. 8, 2025 /PRNewswire/ -- On September 8, 2025, IAA MOBILITY 2025 officially opened in Munich, Germany. GAC made a…

9 months ago

LEADING EUROPEAN PAYMENT PROVIDER, SIBS, SELECTS GEP’S PROCUREMENT SOFTWARE TO MANAGE SOURCE TO CONTRACT GLOBALLY AND DRIVE NEW VALUE

The Portuguese-based company, which operates in more than 25 countries across the world, will use GEP SMART to support its entire…

9 months ago

Advanz Pharma and Alvotech receive European approval for Mynzepli, Biosimilar to Eylea

Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular…

9 months ago

Bybit EU Empowers European Traders with Spot Margin: Up to 10x Leverage, Full Transparency, and Built-In Risk Controls

VIENNA, Aug. 18, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, today announced the launch of d…

9 months ago

Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress

PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of…

10 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the…

10 months ago

Landmark Trial Demonstrates Efficacy of Microcurrent Therapy in Heart Failure: C-MIC II Results Published in the European Journal of Heart Failure

ZUG, Switzerland, July 23, 2025 /PRNewswire/ -- Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II…

10 months ago

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tbingen

TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…

10 months ago

Valneva Announces Lifting of European Medicines Agencys Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ in Elderly

Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

11 months ago

Femasys Announces Historic Milestone with European Approval of FemBloc, the First Non-Surgical Permanent Birth Control

ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in…

11 months ago